BioLineRx Ltd. (BLRX)
BioLineRx has a market cap or net worth of $69.13 million. The enterprise value is $22.25 million.
The latest earnings date was Wednesday, May 11, 2022, before market open.
|Last Earnings Date||May 11, 2022|
BioLineRx has 47.68 million shares outstanding. The number of shares has increased by 27.81% in one year.
|Shares Change (YoY)||+27.81%|
|Shares Change (QoQ)||+0.38%|
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||7.20%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.06.
|Debt / Equity||0.06|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -31.50%, which is considered low.
|Return on Equity (ROE)||-31.50%|
|Return on Assets (ROA)||-26.10%|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$573,474|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -52.63% in the last 52 weeks. The beta is 1.44, so BioLineRx's price volatility has been higher than the market average.
|52-Week Price Change||-52.63%|
|50-Day Moving Average||1.36|
|200-Day Moving Average||1.85|
|Average Volume (30 Days)||203,235|
Short Selling Information
The latest short interest is 477,400, so 1.00% of the outstanding shares have been sold short.
|Short % of Shares Out||1.00%|
|Short % of Float||1.01%|
|Short Ratio (days to cover)||1.99|
|Earnings Per Share (EPS)||-$0.47|
The company has $50.59 million in cash and $3.71 million in debt, giving a net cash position of $46.88 million or $0.98 per share.
|Cash & Cash Equivalents||50.59M|
|Net Cash Per Share||$0.98|
|Book Value Per Share||1.33|
In the last 12 months, operating cash flow was -$22.93 million and capital expenditures -$96,000, giving a free cash flow of -$23.03 million.
|Operating Cash Flow||-22.93M|
|Free Cash Flow||-23.03M|
|FCF Per Share||n/a|
Dividends & Yields
BioLineRx does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
The last stock split was on July 15, 2019. It was a reverse split with a ratio of 1:15.
|Last Split Date||Jul 15, 2019|